Allergy-Induced Respiratory Symptoms

Drug	Drug Name	Drug Description
DB00397	Phenylpropanolamine	A sympathomimetic that was previously used in nasal decongestants and weight loss products, but has been withdrawn by the FDA due to safety risks and lack of efficacy.

Drug	Drug Name	Target	Type
DB00397	Phenylpropanolamine	Amine oxidase [flavin-containing] A	enzyme
DB00397	Phenylpropanolamine	Dopamine D1 receptor	target
DB00397	Phenylpropanolamine	Beta-1 adrenergic receptor	target
DB00397	Phenylpropanolamine	Beta-2 adrenergic receptor	target
DB00397	Phenylpropanolamine	Alpha-2 adrenergic receptors	target

Drug	Drug Name	Phase	Status	Count